Tissue Regenix Group announced the appointment of Mike Barker as Chief Financial Officer (CFO). Mike will join the Group as CFO and as an Executive Director on the Board with immediate effect having supported Tissue Regenix since the beginning of the year as interim Finance Director. A Chartered Accountant for over 20 years, Mike has experience of both AIM listed and private businesses.

After training with Deloitte, he spent 10 years in their corporate finance advisory business working extensively on private equity transactions before setting up his own consultancy business to assist SME's in the delivery of their strategic plans.